Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

21
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
21
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

970
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
970
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

15
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
15
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

20
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
20
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

24
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
24
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

844
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
844

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atrial fibrillation ablation energy source transition and adjunctive lesion set utilization after commercial release of pulse field ablation.

Heart rhythm·2026
Same author

Same-Day Discharge in Ventricular Ablation: Safety Outcomes and Case Selection.

Journal of cardiovascular electrophysiology·2026
Same author

We Thought You'd Never Ask: Insights From the Health of Elite Retired Australian Female Athletes Survey.

Journal of sport rehabilitation·2026
Same author

Outcomes of Patients With Reduced Left Ventricular Function Undergoing Left Atrial Appendage Occlusion.

JACC. Clinical electrophysiology·2026
Same author

Cardioembolic Stroke in ATTR Amyloidosis: What's Rhythm Got to Do With It?

Journal of the American College of Cardiology·2026
Same author

Women-Specific Health Factors in Community-Level Australian Football Players.

Journal of sport rehabilitation·2026

Related Experiment Video

Updated: Jul 8, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K

Repeat catheter ablation for atrial fibrillation.

Mark S Brahier1, Daniel J Friedman1, Tristram D Bahnson1

  • 1Electrophysiology Section, Duke Heart Center, Duke University Hospital & Duke Clinical Research Institute, Durham, North Carolina.

Heart Rhythm
|December 15, 2023
PubMed
Summary

Repeat catheter ablation for atrial fibrillation (AF) is complex, with recurrence often driven by non-pulmonary vein triggers. More research is needed to guide optimal strategies for repeat AF ablation.

Keywords:
Atrial fibrillationMechanism of recurrenceNon-pulmonary vein triggersProcedural strategiesRepeat catheter ablation

More Related Videos

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.4K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.7K

Related Experiment Videos

Last Updated: Jul 8, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.4K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.7K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Device Technology

Background:

  • Catheter ablation is a standard treatment for atrial fibrillation (AF), improving patient outcomes.
  • Guidelines exist for initial ablation, but evidence for repeat procedures is limited.
  • Recurrent AF after ablation presents unique challenges and requires specific management strategies.

Purpose of the Study:

  • To review the rationale, mechanisms, and strategies for repeat catheter ablation in patients with recurrent AF.
  • To identify gaps in evidence and areas requiring further research for redo ablation procedures.
  • To discuss the impact of emerging technologies like pulsed field ablation on AF management.

Main Methods:

  • Literature review focusing on repeat catheter ablation for atrial fibrillation.
  • Analysis of mechanisms of AF recurrence post-ablation.
  • Examination of patient selection, procedural timing, and technical approaches for repeat procedures.
  • Discussion of comorbidity management and complication risks.

Main Results:

  • Recurrent AF is often caused by non-pulmonary vein triggers, but empiric lesion sets lack strong evidence.
  • Current data from de novo ablation trials do not fully translate to redo ablation efficacy.
  • Pulsed field ablation may offer new safety and effectiveness profiles for both initial and repeat ablations.

Conclusions:

  • Repeat AF ablation requires careful patient selection and consideration of recurrence mechanisms.
  • Optimal timing and procedural strategies for repeat ablation remain areas for investigation.
  • Large randomized trials are essential to establish best practices for repeat catheter ablation in AF management.